Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi V Russell

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Pediatrics|July 20, 2023
Parent-Reported Clinical Utility of Pediatric Genomic SequencingHadley Stevens Smith, Bart S Ferket, Bruce D Gelb, et al.
Journal of Pediatric Surgery|June 19, 2012
Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in childrenSaif F Hassan, Shawn Mathur, Thomas J Magliaro, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)Kathryn A Phillips, Julia R Trosman, Michael P Douglas, et al.
Pediatric Blood & Cancer|July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factorsSarah B Whittle, Valeria Smith, Allison Silverstein, et al.
Blood|November 16, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytesKarin C M Straathof, Catherine M Bollard, Uday Popat, et al.
Pediatric Blood & Cancer|June 15, 2011
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) studyHeidi V Russell, Susan G Groshen, Tasnim Ara, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2022
Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methodsBart S Ferket, Zach Baldwin, Priyanka Murali, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Pediatrics|July 20, 2023
Parent-Reported Clinical Utility of Pediatric Genomic SequencingHadley Stevens Smith, Bart S Ferket, Bruce D Gelb, et al.
Journal of Pediatric Surgery|June 19, 2012
Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in childrenSaif F Hassan, Shawn Mathur, Thomas J Magliaro, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)Kathryn A Phillips, Julia R Trosman, Michael P Douglas, et al.
Pediatric Blood & Cancer|July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factorsSarah B Whittle, Valeria Smith, Allison Silverstein, et al.
Blood|November 16, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytesKarin C M Straathof, Catherine M Bollard, Uday Popat, et al.
Pediatric Blood & Cancer|June 15, 2011
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) studyHeidi V Russell, Susan G Groshen, Tasnim Ara, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2022
Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methodsBart S Ferket, Zach Baldwin, Priyanka Murali, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Pageof 5